Research hero image

Research

New Kidney Cancer Immunotherapy Research Projects Funded thumbnail image

New Kidney Cancer Immunotherapy Research Projects Funded

KCA, Research
Two investigators recently received funding from the Cancer Research Institute (CRI) for research on improved immunotherapy approaches to treating kidney cancer. CRI awarded these investigators in addition to a joint Kidney Cancer Association-CRI award earmarked to fund a kidney cancer project. https://www.kidneycancer.org/qa-david-braun/ Dr. David Braun, a medical oncologist and Assistant Professor of Medicine at the Yale School of Medicine, was…
Read More
Q & A: Dr. Sidi Chen, KCA-CRI CLIP Grant Recipient thumbnail image

Q & A: Dr. Sidi Chen, KCA-CRI CLIP Grant Recipient

KCA, Research
Sidi Chen, PhD, was named the 2025 Kidney Cancer Association-Cancer Research Institute Clinic and Laboratory Integration Program (CLIP) Investigator to research "Initial development of a CAR-T-drug conjugate against solid tumor and application in kidney cancer." Dr. Chen, Associate Professor of Genetics and of Neurosurgery at the Yale School of Medicine, plans to pair chimeric antigen receptor (CAR)-T-cell therapy, which has…
Read More
Why We Must Restore Funding for the CDMRP thumbnail image

Why We Must Restore Funding for the CDMRP

KCA, Research
The Congressionally Directed Medical Research Programs (CDMRP) was created by Congress in 1992 to fund high-impact medical research—especially in areas overlooked by traditional sources—through the Department of Defense. CDMRP began with breast cancer research and has since expanded to support many conditions affecting both Service Members and civilians. https://www.kidneycancer.org/protect-federal-kidney-cancer-research-funding/ The CDMRP’s unique strength lies in backing high-risk, high-reward science: early-stage, innovative ideas that…
Read More

Research Update: New Kidney Cancer Treatment Method, Trial Ongoing

KCA, Research
Dr. Toni Choueiri and Dr. Rizwan Romee received a KCA research award in 2021 for their project “Adoptive cytokine-induced memory-like natural killer cell therapy alone or in combination with avelumab for immunotherapy-refractory advanced renal cell carcinoma.” This technique could represent a new type of immunotherapy treatment Choueiri, Romee, and Dr. Vincent Xu, shared an update on their research, which has…
Read More